Sideroblastic Anemia: Causes, Symptoms, Diagnosis, and Treatment
Figure 1. Illustration showing defective heme synthesis and mitochondrial iron accumulation in sideroblastic anemia.
Introduction
Sideroblastic anemia (SA) is a rare and heterogeneous group of blood disorders caused by defective heme synthesis. Although the body has adequate or even excessive iron stores, the iron cannot be effectively incorporated into hemoglobin. Instead, it accumulates within the mitochondria of developing erythroblasts, forming ring sideroblasts, the characteristic hallmark of the disease.
Sideroblastic anemia may be either congenital or acquired. Inherited forms are usually caused by genetic mutations affecting enzymes involved in heme synthesis, whereas acquired forms are associated with myelodysplastic syndrome (MDS), chronic alcohol use, certain medications, nutritional deficiencies, and heavy metal poisoning. Early diagnosis is essential because prolonged iron overload may damage vital organs such as the liver, heart, and endocrine glands.
Sideroblastic anemia is a rare type of anemia caused by defects in heme synthesis. To learn more about anemia classification, causes, symptoms, and diagnosis, read our comprehensive article https://smartmedixlab.blogspot.com/2026/07/anemia-causes-symptoms-diagnosis.htmlabout Anemia.
Classification
Sideroblastic anemia is classified into two major types.
Congenital Sideroblastic Anemia
This inherited form usually appears during childhood or early adulthood. Most cases are caused by mutations in the ALAS2 gene, while less common forms are associated with other genetic defects affecting mitochondrial function or heme production.
Acquired Sideroblastic Anemia
This form develops later in life and is more common than the congenital type. It may occur as part of myelodysplastic syndrome (MDS) or secondary to alcohol abuse, medications, heavy metal toxicity, or nutritional deficiencies. Many acquired cases improve after treating the underlying cause.
Causes
The causes of sideroblastic anemia differ according to its type.
Congenital Causes
The congenital form is mainly caused by inherited mutations affecting enzymes responsible for heme synthesis. The most common mutation involves the ALAS2 gene, although several other rare genetic abnormalities have also been identified.
Acquired Causes
Common acquired causes include:
Myelodysplastic syndrome (MDS).
Chronic alcohol consumption.
Lead poisoning.
Copper deficiency.
Vitamin B6 (pyridoxine) deficiency.
Medications such as isoniazid, chloramphenicol, and linezolid.
Certain chemotherapeutic agents.
Pathophysiology
The pathophysiology of sideroblastic anemia is characterized by impaired heme synthesis, preventing iron from being incorporated into hemoglobin. As a result, iron accumulates within the mitochondria of developing erythroblasts, leading to ineffective erythropoiesis and systemic iron overload.
Figure 2. Simplified diagram of heme synthesis showing defective iron incorporation and mitochondrial iron accumulation in sideroblastic anemia.
Defective Heme Synthesis
The primary abnormality involves reduced activity of enzymes responsible for heme production. Congenital forms are commonly caused by mutations in the ALAS2 gene, whereas acquired forms result from toxins, alcohol, or medications that inhibit enzymes such as ferrochelatase. Consequently, hemoglobin production decreases.
Mitochondrial Iron Accumulation
Iron continues to enter the mitochondria normally but cannot be incorporated into protoporphyrin to form heme. The excess iron gradually accumulates inside the mitochondria.
Ring Sideroblast Formation
Iron-loaded mitochondria surround the nucleus of developing erythroblasts, producing the characteristic ring sideroblasts observed on Prussian blue-stained bone marrow aspirates, which confirm the diagnosis.
Ineffective Erythropoiesis
Excess intracellular iron generates oxidative stress that damages erythroid precursors. Many of these immature cells are destroyed within the bone marrow before reaching maturity, resulting in decreased red blood cell production.
Iron Overload
Despite anemia, intestinal iron absorption often continues or increases. Excess iron is deposited in organs such as the liver, heart, pancreas, and endocrine glands, potentially causing secondary hemochromatosis and organ dysfunction.
Clinical Features
The clinical presentation depends on the severity of anemia and the underlying cause. Some patients remain asymptomatic, while others develop progressive symptoms.
General Symptoms
Common symptoms include:
Fatigue.
Generalized weakness.
Pallor.
Dizziness.
Shortness of breath on exertion.
Palpitations.
Headache.
Reduced exercise tolerance.
Signs of Iron Overload
Patients with chronic iron overload may develop:
Hepatomegaly.
Splenomegaly.
Cardiac dysfunction.
Diabetes mellitus.
Endocrine abnormalities.
Additional manifestations may occur depending on the underlying cause, such as neurological symptoms in lead poisoning or features of myelodysplastic syndrome.
Diagnosis
The diagnosis of sideroblastic anemia is based on clinical evaluation together with laboratory investigations and bone marrow examination.
Diagnostic tests include:
Complete blood count (CBC).
Peripheral blood smear.
Iron studies.
Bone marrow aspiration with Prussian blue stain.
Serum vitamin B6 and copper levels when indicated.
Blood lead level if lead poisoning is suspected.
Genetic testing in suspected congenital cases.
Laboratory Findings
Laboratory investigations typically demonstrate anemia with increased body iron stores.
Common findings include:
Hemoglobin (Hb): Decreased.
Red blood cell (RBC) count: Usually decreased.
Mean corpuscular volume (MCV): Usually decreased in congenital forms but may be normal or increased in acquired forms.
Mean corpuscular hemoglobin (MCH): Decreased.
Mean corpuscular hemoglobin concentration (MCHC): Decreased.
Serum iron: Increased.
Serum ferritin: Increased.
Total iron-binding capacity (TIBC): Normal or decreased.
Transferrin saturation: Increased.
Serum transferrin receptor (sTfR): Usually normal.
Bilirubin and urobilinogen: May be mildly elevated due to ineffective erythropoiesis.
Unlike iron deficiency anemia, patients with sideroblastic anemia usually have normal or increased iron stores despite reduced hemoglobin synthesis.
Peripheral Blood Smear
Peripheral blood smear findings vary according to the underlying cause but commonly include hypochromic, microcytic, or dimorphic red blood cells. Anisocytosis and poikilocytosis are frequently observed, while basophilic stippling may be present, particularly in cases of lead poisoning.
Bone Marrow Findings
Bone marrow examination is the gold standard for confirming sideroblastic anemia. Typical findings include erythroid hyperplasia, increased iron stores, and numerous ring sideroblasts demonstrated by Prussian blue staining. In patients with myelodysplastic syndrome, dysplastic changes involving other hematopoietic cell lines may also be present.
Differential Diagnosis
Sideroblastic anemia should be differentiated from other microcytic and macrocytic anemias because several disorders share similar clinical and laboratory findings.
Iron Deficiency Anemia (IDA)
Iron deficiency anemia is the most common cause of microcytic anemia and is characterized by low serum iron, low ferritin, and increased total iron-binding capacity (TIBC). In contrast, sideroblastic anemia typically presents with increased serum iron and ferritin, normal or decreased TIBC, and the presence of ring sideroblasts in the bone marrow.
Thalassemia
Both sideroblastic anemia and thalassemia may present with microcytic, hypochromic red blood cells. However, thalassemia usually has a normal or increased red blood cell count and abnormal hemoglobin electrophoresis, whereas ring sideroblasts are absent.
Anemia of Chronic Disease (ACD)
Anemia of chronic disease is commonly associated with chronic infections, inflammatory disorders, or malignancy. Although ferritin levels may be normal or elevated, serum iron and TIBC are typically decreased. Bone marrow examination shows iron stored within macrophages rather than ring sideroblasts.
Lead Poisoning
Lead poisoning may produce microcytic anemia with basophilic stippling on the peripheral blood smear. Elevated blood lead levels, neurological manifestations, and gastrointestinal symptoms help distinguish it from congenital sideroblastic anemia.
Myelodysplastic Syndrome (MDS)
Older adults with acquired sideroblastic anemia should be evaluated for myelodysplastic syndrome. Bone marrow examination and cytogenetic studies help confirm the diagnosis and identify clonal abnormalities.
Treatment
Treatment depends on the underlying cause, the severity of anemia, and the presence of iron overload.
Remove the Underlying Cause
Acquired sideroblastic anemia may improve after eliminating the causative factor. Patients should discontinue alcohol consumption, avoid exposure to heavy metals such as lead, and stop offending medications whenever possible. Nutritional deficiencies should also be corrected.
Pyridoxine (Vitamin B6) Therapy
High-dose pyridoxine is the first-line treatment for X-linked congenital sideroblastic anemia. Many patients respond with improved hemoglobin production because vitamin B6 enhances the residual activity of the ALAS2 enzyme.
Copper Replacement
Patients with copper deficiency should receive appropriate copper supplementation, which may restore normal erythropoiesis.
Blood Transfusion
Packed red blood cell transfusions may be required for patients with severe symptomatic anemia or those who fail to respond to medical therapy.
Iron Chelation Therapy
Patients with significant iron overload or those receiving repeated blood transfusions should receive iron chelation therapy, such as deferoxamine or deferasirox, to reduce iron accumulation and prevent organ damage.
Complications
If left untreated, sideroblastic anemia may result in several serious complications, mainly due to chronic iron overload.
Common complications include:
Secondary hemochromatosis.
Liver fibrosis and cirrhosis.
Cardiomyopathy, arrhythmias, and heart failure.
Diabetes mellitus due to pancreatic iron deposition.
Endocrine dysfunction.
Progression to acute myeloid leukemia (AML) in some patients with myelodysplastic syndrome.
Prognosis
The prognosis depends on the underlying cause and the patient's response to treatment.
Acquired sideroblastic anemia generally has an excellent prognosis once the causative factor is removed. Congenital forms can often be successfully managed with long-term pyridoxine therapy and careful monitoring of iron overload. However, cases associated with myelodysplastic syndrome usually have a less favorable prognosis because of persistent bone marrow dysfunction and the potential risk of progression to acute leukemia.
Prevention
Although inherited forms cannot be prevented, many acquired cases can be avoided by reducing exposure to known risk factors.
Preventive measures include:
Avoid excessive alcohol consumption.
Minimize occupational exposure to lead and other heavy metals.
Maintain adequate vitamin B6 and copper intake.
Monitor patients receiving medications that interfere with heme synthesis, such as isoniazid.
Diagnose and treat underlying disorders early to reduce the risk of iron overload.
Conclusion
Sideroblastic anemia is a rare hematologic disorder characterized by impaired heme synthesis despite adequate or increased iron stores. The resulting accumulation of iron within erythroblast mitochondria produces the characteristic ring sideroblasts seen on bone marrow examination. Early diagnosis, identification of the underlying cause, and appropriate treatment are essential to prevent iron overload and its complications. With timely management, many acquired cases are reversible, while congenital forms can often be effectively controlled with lifelong therapy and regular follow-up.
Frequently Asked Questions (FAQs)
What is the hallmark of sideroblastic anemia?
The hallmark of sideroblastic anemia is the presence of ring sideroblasts in the bone marrow, identified using Prussian blue staining.
Is sideroblastic anemia caused by iron deficiency?
No. Patients usually have normal or increased iron stores, but their bodies cannot effectively incorporate iron into hemoglobin because of defective heme synthesis.
Can sideroblastic anemia be cured?
Many acquired forms are reversible once the underlying cause is removed. Congenital forms usually require long-term treatment and regular monitoring.
Why does iron overload occur in sideroblastic anemia?
Iron overload develops because iron absorption continues despite ineffective red blood cell production. The excess iron accumulates in organs such as the liver, heart, and pancreas, increasing the risk of organ damage.
References
Hoffbrand AV, Higgs DR, Keeling DM, Mehta AB. Postgraduate Haematology. 8th ed. Wiley-Blackwell; 2023.
Rodak BF, Fritsma GA, Keohane EM. Hematology: Clinical Principles and Applications. 6th ed. Elsevier; 2020.
Greer JP, Arber DA, Glader B, et al. Wintrobe's Clinical Hematology. 15th ed. Wolters Kluwer; 2023.
Kaushansky K, Lichtman MA, Prchal JT, et al. Williams Hematology. 10th ed. McGraw-Hill Education; 2021.
Cappellini MD, Motta I. Anemia in Clinical Practice: Definition and Classification. Hematology Reports. 2015;7(4):5843.
MSD Manual Professional Edition. Sideroblastic Anemia.
StatPearls Publishing. Sideroblastic Anemia. Treasure Island (FL): StatPearls Publishing; Updated 2025.
World Health Organization (WHO). Haematological Disorders and Anaemia: Technical Guidance. Geneva: WHO.
Comments
Post a Comment